GPT and metabolic dysfunction-associated steatotic liver disease: Still, VCTE remains more cost-effective and risk free than similar imaging modalities such as CT or MRI.17–19 Indeed, VCTE has already been implemented by many experts and society guidelines as an important step for assessing disease severity in NAFLD patients.20,21 In addition, the constitutive demographic data (age, sex, and presence of type 2 diabetes) and serum biomarkers (aspartate aminotransferase, alanine transaminase, and platelets) used in Agile 3+ and 4 are incorporated in the standard examination of any liver disease.